D. C. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
D. C. Anderson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Darina Gromyko
Department of Surgery, Haukeland University Hospital, N-5021 Bergen, Norway
1 shared publication - Diane Kagabo
Department of Molecular Biology, University of Bergen, N-5020 Bergen, Norway
1 shared publication Donald G. Payan
Rigel Inc., 1180 Veterans Blvd., South San Francisco, CA 94080
1 shared publicationEric U. Selker
Institute of Molecular Biology, University of Oregon, Eugene OR 97403
1 shared publicationGeorge R. Green
Southern School of Pharmacy, Mercer University, Atlanta GA 30341
1 shared publication- J E Varhaug
Department of Breast and Endocrine Surgery, Haukeland University Hospital, Bergen, Norway
1 shared publication
Latest Publications
- 15 May 2024
- Published by Elsevier in Journal of Proteomics
- Vol. 302, 105197
Proteomes of plasmodium knowlesi early and late ring-stage parasites and infected host erythrocytes
- 15 May 2024
- Published by Elsevier in Journal of Proteomics
- Vol. 302, 105197
Proteomes of plasmodium knowlesi early and late ring-stage parasites and infected host erythrocytes
- 7 June 2010
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (25) , 5244-5257
Extensive and Varied Modifications in Histone H2B of Wild-Type and Histone Deacetylase 1 Mutant Neurospora crassa
DNA methylation is deficient in a histone deacetylase 1 (HDA1) mutant (hda-1) strain of Neurospora crassa with inactivated histone deacetylase 1. Difference two-dimensional (2D) gels identified the primary histone deacetylase 1 target as histone H2B. Acetylation was identified by LC−MS/MS at five different lysines in wild-type H2B and at 11 lysines in hda-1 H2B, suggesting Neurospora H2B is a complex combination of different acetylated species. Individual 2D gel spots were shifted by single lysine acetylations. FTICR MS-observed methylation ladders identify an ensemble of 20−25 or more modified forms for each 2D gel spot. Twelve different lysines or arginines were methylated in H2B from the wild type or hda-1; only two were in the N-terminal tail. Arginines were modified by monomethylation, dimethylation, or deimination. H2B from wild-type and hda-1 ensembles may thus differ by acetylation at multiple sites, and by additional modifications. Combined with asymmetry-generated diversity in H2B structural states in nucleosome core particles, the extensive modifications identified here can create substantial histone-generated structural diversity in nucleosome core particles.
- 7 June 2010
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (25) , 5244-5257
Extensive and Varied Modifications in Histone H2B of Wild-Type and Histone Deacetylase 1 Mutant Neurospora crassa
DNA methylation is deficient in a histone deacetylase 1 (HDA1) mutant (hda-1) strain of Neurospora crassa with inactivated histone deacetylase 1. Difference two-dimensional (2D) gels identified the primary histone deacetylase 1 target as histone H2B. Acetylation was identified by LC−MS/MS at five different lysines in wild-type H2B and at 11 lysines in hda-1 H2B, suggesting Neurospora H2B is a complex combination of different acetylated species. Individual 2D gel spots were shifted by single lysine acetylations. FTICR MS-observed methylation ladders identify an ensemble of 20−25 or more modified forms for each 2D gel spot. Twelve different lysines or arginines were methylated in H2B from the wild type or hda-1; only two were in the N-terminal tail. Arginines were modified by monomethylation, dimethylation, or deimination. H2B from wild-type and hda-1 ensembles may thus differ by acetylation at multiple sites, and by additional modifications. Combined with asymmetry-generated diversity in H2B structural states in nucleosome core particles, the extensive modifications identified here can create substantial histone-generated structural diversity in nucleosome core particles.
- Open Access
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
A novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.
- 1 January 2009
- Published by Springer Nature in BMC Biochemistry
- Vol. 10 (1) , 15
Open AccessA novel human NatA Nα-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1)
Protein acetylation is among the most common protein modifications. The two major types are post-translational Nε-lysine acetylation catalyzed by KATs (Lysine acetyltransferases, previously named HATs (histone acetyltransferases) and co-translational Nα-terminal acetylation catalyzed by NATs (N-terminal acetyltransferases). The major NAT complex in yeast, NatA, is composed of the catalytic subunit Naa10p (N alpha acetyltransferase 10 protein) (Ard1p) and the auxiliary subunit Naa15p (Nat1p). The NatA complex potentially acetylates Ser-, Ala-, Thr-, Gly-, Val- and Cys- N-termini after Met-cleavage. In humans, the homologues hNaa15p (hNat1) and hNaa10p (hArd1) were demonstrated to form a stable ribosome associated NAT complex acetylating NatA type N-termini in vitro and in vivo.
- 7 November 2006
- Published by Wiley in Biopolymers
- Vol. 88 (1) , 55-63
Gas phase dimerization of neuropeptide head activator analogs useful for the noncovalent constraint of peptides
- 7 November 2006
- Published by Wiley in Biopolymers
- Vol. 88 (1) , 55-63
Gas phase dimerization of neuropeptide head activator analogs useful for the noncovalent constraint of peptides